A new group of anti-lipopolysaccharide factors from Marsupenaeus japonicus functions in antibacterial response

Dev Comp Immunol. 2015 Jan;48(1):33-42. doi: 10.1016/j.dci.2014.09.001. Epub 2014 Sep 15.

Abstract

Anti-lipopolysaccharide factors (ALFs) are a group of critical effector molecules with a broad spectrum of antimicrobial activities in crustaceans. Four groups of ALFs (A, B, C, and D) have been identified in peneaid shrimp. In the study, we identified a new group of ALFs (designated as MjALF-E) from Marsupenaeus japonicus. This new group (group E) included MjALF-E1 and E2. MjALF-E1 was highly expressed in hemocytes, heart, and intestine, whereas E2 was highly expressed in gills, stomach, and intestine. Expressions of both MjALF-E1 and E2 were upregulated by bacterial challenge. Synthesized LPS-binding domain peptides of MjALF-E1 and E2 strongly bind to bacterial cell wall components lipopolysaccharide (LPS) and peptidoglycan (PGN). The recombinant rMjALF-E2 showed relatively weak binding activity to LPS and PGN. Both synthesized peptides and rMjALF-E2 exhibited antimicrobial activity against Gram-negative bacteria, whereas rMjALF-E2 could promote the clearance of bacteria in vivo. After knockdown of MjALF-E2 and infection with Vibrio anguillarum, shrimp showed high and rapid mortality compared with GFPi shrimp. These results suggest that MjALF-Es serves a protective function against bacterial infection in shrimp.

Keywords: Anti-lipopolysaccharide factors; Antimicrobial peptide; Bacterial clearance; Marsupenaeus japonicus; RNA interference; Shrimp innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Antimicrobial Cationic Peptides / genetics
  • Antimicrobial Cationic Peptides / pharmacology*
  • Arthropod Proteins / genetics
  • Arthropod Proteins / pharmacology*
  • Base Sequence
  • Gastric Mucosa / metabolism
  • Gills / metabolism
  • Gram-Negative Bacteria / immunology
  • Hemocytes / metabolism
  • Intestinal Mucosa / metabolism
  • Lipopolysaccharides / immunology*
  • Molecular Sequence Data
  • Myocardium / metabolism
  • Penaeidae / immunology*
  • Penaeidae / metabolism
  • Peptidoglycan / immunology
  • Protein Binding
  • RNA Interference
  • RNA, Small Interfering
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Sequence Alignment
  • Sequence Analysis, DNA
  • Vibrio / immunology
  • Vibrio Infections / drug therapy
  • Vibrio Infections / immunology*

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Arthropod Proteins
  • Lipopolysaccharides
  • Peptidoglycan
  • RNA, Small Interfering
  • Recombinant Proteins
  • antilipopolysaccharide factor (Limulus)